Garvan Institute of Medical Research

The Garvan Institute of Medical Research was founded in 1963 by the Sisters of Charity. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with approximately 500 scientists, students and support staff. Funds for its establishment were provided by a hospital appeal. Helen Mills, the largest donor, asked for the centre to be named after her father, the late James Patrick Garvan (1843-1896), a distinguished New South Wales parliamentarian and business leader. Garvan's research programs are based around the major diseases in today's society: cancer, diabetes, osteoporosis, Alzheimer's, Parkinson's; as well as eating disorders, and autoimmune and inflammatory conditions such as rheumatoid arthritis and asthma. It specialises in genetic and molecular technologies, and emphasises collaborative research. The current director is John Mattick.

Website
http://www.garvan.org.au
Wikipedia
http://en.wikipedia.org/wiki/Garvan_Institute_of_Medical_Research

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Oncology & Cancer

Researchers reveal key to targeting dormant cancer cells

An international team of scientists has uncovered the unique set of genes that keeps some cancer cells dormant. Led by Associate Professor Tri Phan and Professor Peter Croucher at the Garvan Institute of Medical Research ...

Medical research

Comfort food leads to more weight gain during stress

It's no secret that overindulging on high-calorie foods can be detrimental to health, but it turns out that under stress, watching what you eat may be even more important.A team led by Professor Herbert Herzog, Head of the ...

Oncology & Cancer

A more accurate method to diagnose cancer subtypes

Developed by researchers at the Garvan Institute of Medical Research, this potential diagnostic method screens a cancer sample for 'fusion genes', estimated to be linked to one in five cancers, and may provide a more accurate ...

Oncology & Cancer

Turbo-charging chemotherapy for lung cancer

A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers.

Genetics

Genomics is disrupting the healthcare sector

Affordable, rapid DNA sequencing is causing a revolution in medicine and healthcare globally—and it's happening now, says Thomas Barlow (Barlow Advisory), the author of the landmark Garvan Global Genomics Report, which ...

page 1 from 6